Driven by a Growing Pipeline of Drugs Targeting Various Chronic Disorders, the Large Volume Wearable Injectors Market is Anticipated to Grow at a Rapid Pace (CAGR ~40%), Predicts, Roots Analysis

Driven by a Growing Pipeline of Drugs Targeting Various Chronic Disorders, the Large Volume Wearable Injectors Market is Anticipated to Grow at a Rapid Pace (CAGR ~40%), Predicts, Roots Analysis

PR Newswire

LONDON, Feb. 6, 2019

LONDON, Feb. 6, 2019 /PRNewswire/ -- Roots Analysis has announced the addition of "Large Volume Wearable Injectors Market (4th Edition), 2018-2030" report to its list of offerings.

Roots_Analysis_Logo

Harsimran Kaur, the principal analyst, stated, "The large volume wearable injectors continue to retain the interest of both drug developers and medical device manufacturers. This can be attributed to the various benefits offered by these devices. In fact, over 50 devices are currently under development / approved for the delivery of both insulin and non-insulin drugs."

The report presents opinions on several key aspects of the market. Among other elements, it includes:

Kaur further remarked, "The innovation in the field is primarily being driven by start-ups / small companies. Of all the companies developing large volume wearable injectors for non-insulin drugs, 50% are based in North America. Examples of firms based in this region include (in alphabetical order, no selection criteria) Enable Injections, Medipacs, SteadyMed Therapeutics, scPharmaceuticals and West Pharmaceutical Services. Examples of start-ups based in other geographical regions that have undertaken initiatives in this domain include (in alphabetical order, no selection criteria) Debiotech, Subcuject, ViCentra, Weibel CDS and Eoflow. In addition, a number of established companies are also making substantial contributions in this field; prominent players include (in alphabetical order, no selection criteria) 3M, Becton Dickinson, Insulet, West Pharmaceutical Services and Ypsomed. Historical and current uptake trends clearly demonstrate the growing popularity of these devices. With many developers striving to incorporate more user-friendly and advanced features in their devices, the adoption of large volume wearable injectors is expected to steadily increase in the mid-long term."

The report also features inputs from a number of eminent industry stakeholders, with detailed transcripts of discussions held with the following individuals:

The research covers detailed profiles and assesses product portfolios of several companies, including (illustrative list, no selection criteria):

For additional details, please visit: https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html or email sales@rootsanalysis.com                                                                                                                                                                                                                        

Contact:
Gaurav Chaudhary
+1(415)800-3415
Gaurav.Chaudhary@rootsanalysis.com

 

Voltar noticias em Inglês